Tumor heterogeneity: causes and consequences.
暂无分享,去创建一个
[1] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[2] A. Haddow. Cellular inhibition and the origin of cancer, with special reference to the mode of action of the carcinogenic hydrocarbons , 1937 .
[3] R. Weinberg,et al. The Biology of Cancer , 2006 .
[4] S. Goldhor. Ecology , 1964, The Yale Journal of Biology and Medicine.
[5] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[6] K. Illmensee,et al. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[7] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[8] R. Weinberg,et al. Structure of the intermediates leading to the integrated provirus. , 1977, Biochimica et biophysica acta.
[9] M. Kimura,et al. The neutral theory of molecular evolution. , 1983, Scientific American.
[10] P. Fialkow,et al. Clonal origin of human tumors. , 1979, Annual review of medicine.
[11] I. Fidler,et al. Biological diversity in metastatic neoplasms: origins and implications. , 1982, Science.
[12] G. Heppner. Tumor heterogeneity. , 1984, Cancer research.
[13] W. Hamilton,et al. The Evolution of Cooperation , 1984 .
[14] M. Weiss. Biological Anthropology: The Neutral Theory of Molecular Evolution. Motoo Kimura , 1985 .
[15] G. Schlimok,et al. Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[16] F. Miller,et al. Analysis of tumour cell composition in tumours composed of paired mixtures of mammary tumour cell lines. , 1987, British Journal of Cancer.
[17] J. Leith,et al. Growth properties of artificial heterogeneous human colon tumors. , 1987, Cancer research.
[18] O. Kallioniemi. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. , 1988, Cytometry.
[19] F. Miller,et al. Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors. , 1988, Cancer research.
[20] M. Kimura. [Recent developments of the neutral theory of molecular evolution, and a world view based on the neutral theory]. , 1989, Idengaku zasshi.
[21] G. Heppner,et al. Cancer cell societies and tumor progression , 1993, Stem cells.
[22] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[23] K. Hess,et al. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[25] T. Wheeler,et al. Heterogeneity of prostate cancer in radical prostatectomy specimens. , 1994, Urology.
[26] R. Lenski,et al. Evidence for multiple adaptive peaks from populations of bacteria evolving in a structured habitat. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Izbicki,et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] T C Gasser,et al. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. , 1995, Cytometry.
[29] S. Coons,et al. Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. , 1995, Cancer research.
[30] N. Konishi,et al. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. , 1995, The American journal of pathology.
[31] B. Johansson,et al. Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups , 1995, Genes, chromosomes & cancer.
[32] Lars Holmgren,et al. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.
[33] F. Mitelman,et al. Clonal heterogeneity in breast cancer: Karyotypic comparisons of multiple intra—and extra—tumorous samples from 3 patients , 1995, International journal of cancer.
[34] J. Andersen,et al. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. , 1996, Cancer research.
[35] E Gabrielson,et al. Genetic divergence in the clonal evolution of breast cancer. , 1996, Cancer research.
[36] J. Califano,et al. 11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .
[37] D J Ruiter,et al. HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS , 1996, The Journal of pathology.
[38] C. Janeway. Immunobiology: The Immune System in Health and Disease , 1996 .
[39] W. Bodmer,et al. Polyclonal Origin of Colonic Adenomas in an XO/XY Patient with FAP , 1996, Science.
[40] W. Giaretti,et al. Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy. , 1996, The American journal of pathology.
[41] A. Schäffer,et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. , 1997, Cancer research.
[42] I. Tomlinson,et al. Game-theory models of interactions between tumour cells. , 1997, European journal of cancer.
[43] W. F. Bodmer,et al. Modelling the consequences of interactions between tumour cells. , 1997, British Journal of Cancer.
[44] Michael Travisano,et al. Adaptive radiation in a heterogeneous environment , 1998, Nature.
[45] N. Maitland,et al. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. , 1998, Cancer research.
[46] R. Hanada,et al. Spontaneous regression of localized neuroblastoma detected by mass screening. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] M. Speicher,et al. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[48] A. Schäffer,et al. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization. , 1999, The American journal of pathology.
[49] D. Bostwick,et al. Allelic imbalance in the clonal evolution of prostate carcinoma , 1999, Cancer.
[50] M. Slattery,et al. Regional reproducibility of microsatellite instability in sporadic colorectal cancer , 1999, Genes, chromosomes & cancer.
[51] M. Lensch,et al. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia , 1999, Leukemia.
[52] R. Hruban,et al. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. , 2000, Cancer research.
[53] P. Chesson. Mechanisms of Maintenance of Species Diversity , 2000 .
[54] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[55] M J Bissell,et al. The influence of the microenvironment on the malignant phenotype. , 2000, Molecular medicine today.
[56] Mel Greaves,et al. Cancer: The Evolutionary Legacy , 2000 .
[57] W. Falk,et al. A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. , 2001, Cancer research.
[58] E. Laconi,et al. A growth-constrained environment drives tumor progression in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[59] B. Hero,et al. Neuroblastoma , 2007, The Lancet.
[60] I. Tomlinson,et al. Loss of heterozygosity analysis: Practically and conceptually flawed? , 2002, Genes, chromosomes & cancer.
[61] R. Solé,et al. Metapopulation dynamics and spatial heterogeneity in cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[62] T. Czárán,et al. Chemical warfare between microbes promotes biodiversity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[63] M. Blagosklonny. Oncogenic resistance to growth-limiting conditions , 2002, Nature Reviews Cancer.
[64] U. Lehmann,et al. Marked Intratumoral Heterogeneity of c-myc and CyclinD1 But Not of c-erbB2 Amplification in Breast Cancer , 2002, Laboratory Investigation.
[65] J. Kuriyan,et al. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. , 2002, Cancer cell.
[66] N. Stoecklein,et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer , 2002, The Lancet.
[67] Claude Preudhomme,et al. Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment. , 2002, Blood.
[68] J. Köllermann,et al. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[69] Ingo Roeder,et al. A novel dynamic model of hematopoietic stem cell organization based on the concept of within-tissue plasticity. , 2002, Experimental hematology.
[70] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[71] A. ADoefaa,et al. ? ? ? ? f ? ? ? ? ? , 2003 .
[72] M Hummel,et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.
[73] Annuska M Glas,et al. Gene expression profiles of primary breast tumors maintained in distant metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[74] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[75] Armand M. Leroi,et al. Cancer selection , 2003, Nature Reviews Cancer.
[76] W. Thilly. Have environmental mutagens caused oncomutations in people? , 2003, Nature Genetics.
[77] A. Ashworth,et al. Close relatives or distant cousins? , 2003, The Lancet. Oncology.
[78] Robert A Gatenby,et al. Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies. , 2003, Molecular cancer therapeutics.
[79] R. Eils,et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[80] W. Hofmann,et al. Presence of the BCR-ABL mutation Glu255Lys prior to STI571 (imatinib) treatment in patients with Ph+ acute lymphoblastic leukemia. , 2003, Blood.
[81] T. Vincent,et al. An evolutionary model of carcinogenesis. , 2003, Cancer research.
[82] Daniel Pinkel,et al. Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH. , 2003, Genome research.
[83] P. Amarasekare. Competitive coexistence in spatially structured environments: a synthesis , 2003 .
[84] N. Theise. Perspective: stem cells react! Cell lineages as complex adaptive systems. , 2004, Experimental hematology.
[85] G. Nicolson. Generation of phenotypic diversity and progression in metastatic tumor cells , 2004, Cancer and Metastasis Reviews.
[86] S. Leibler,et al. Bacterial Persistence as a Phenotypic Switch , 2004, Science.
[87] Mark J. Murphy,et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. , 2004, Genes & development.
[88] J. Nagy. Competition and natural selection in a mathematical model of cancer , 2004, Bulletin of mathematical biology.
[89] M. König,et al. Clonal variation of the immunogenotype in relapsed ETV6/RUNX1‐positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development , 2004, Genes, chromosomes & cancer.
[90] P. Quesenberry,et al. Differentiation hotspots: the deterioration of hierarchy and stochasm. , 2004, Blood cells, molecules & diseases.
[91] M. Nowak,et al. Dynamics of cancer progression , 2004, Nature Reviews Cancer.
[92] M. Greaves,et al. TEL Deletion Analysis Supports a Novel View of Relapse in Childhood Acute Lymphoblastic Leukemia , 2004, Clinical Cancer Research.
[93] Stephanie Forrest,et al. Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[94] Carlos L Arteaga,et al. Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them? , 2004, Cancer cell.
[95] Ingo Roeder,et al. Conceptual models to understand tissue stem cell organization , 2004, Current opinion in hematology.
[96] S. Lowe,et al. Intrinsic tumour suppression , 2004, Nature.
[97] R. Gangnus,et al. Genomic Profiling of Viable and Proliferative Micrometastatic Cells from Early-Stage Breast Cancer Patients , 2004, Clinical Cancer Research.
[98] B. Druker,et al. Oncogenes and Tumor Suppressors (795 articles) , 2004 .
[99] O. Sieber,et al. Tissue, cell and stage specificity of (epi)mutations in cancers , 2005, Nature Reviews Cancer.
[100] N. Pandis,et al. Cytogenetic manifestations of multiple myeloma heterogeneity , 2005, Genes, chromosomes & cancer.
[101] Kyle Summers,et al. Evolutionary biology of cancer. , 2005, Trends in ecology & evolution.
[102] R. Cardiff,et al. Impaired DNA Replication within Progenitor Cell Pools Promotes Leukemogenesis , 2005, PLoS biology.
[103] Michael R. Green,et al. A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake , 2005, Cell.
[104] J. McGregor. Context , 2018, J. Object Technol..
[105] S. Hughes,et al. Whole Genome Amplification , 2020, Definitions.
[106] J. V. van Dongen,et al. Immunogenotype Changes Prevail in Relapses of Young Children with TEL-AML1-Positive Acute Lymphoblastic Leukemia and Derive Mainly from Clonal Selection , 2005, Clinical Cancer Research.
[107] Mina J Bissell,et al. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? , 2005, Cancer cell.
[108] K. Sircar,et al. Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer. , 2005, Cancer research.
[109] C. Perou,et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. , 2005, Cancer research.
[110] P. Chambon,et al. Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[111] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[112] Xi C. He,et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention , 2006, Nature.
[113] K. Pienta,et al. Evolution of cooperation among tumor cells , 2006, Proceedings of the National Academy of Sciences.
[114] Carissa A. Sanchez,et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.
[115] R. Hill. Identifying cancer stem cells in solid tumors: case not proven. , 2006, Cancer research.
[116] J. Andersen,et al. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases , 2007, Breast Cancer Research and Treatment.
[117] A. Piotrowski,et al. Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity. , 2006, International Journal of Oncology.
[118] C. Klein,et al. Systemic Cancer Progression and Tumor Dormancy: Mathematical Models Meet Single Cell Genomics , 2006, Cell cycle.
[119] K. Coombes,et al. Zonal heterogeneity for gene expression in human pancreatic carcinoma. , 2007, Cancer research.
[120] S. Levin. Evolutionary Dynamics: Exploring the Equations of Life.ByMartin A Nowak.Belknap Press. Cambridge (Massachusetts): Harvard University Press.$35.00. xiii + 363 p; ill.; index. ISBN: 0‐674‐02338‐2. 2006. , 2007 .
[121] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[122] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[123] Mary R. Myerscough,et al. Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions , 2007, Clinical & Experimental Metastasis.
[124] Aleksandar Dakic,et al. Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.
[125] T. Conroy,et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[126] S. Kern,et al. The fuzzy math of solid tumor stem cells: a perspective. , 2007, Cancer research.
[127] K Fenwick,et al. Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy , 2006, British Journal of Cancer.
[128] V. Gadi,et al. Fetal microchimerism in women with breast cancer. , 2007, Cancer research.
[129] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[130] R. Eils,et al. Systemic spread is an early step in breast cancer. , 2008, Cancer cell.
[131] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[132] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[133] E. Sahai,et al. Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement , 2008, Cell.
[134] F. Couch,et al. Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers , 2008, Nature.
[135] Y. Refaeli,et al. B-cell receptor signaling in the genesis and maintenance of B-cell lymphoma. , 2008, Future oncology.
[136] A. Ullrich,et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. , 2008, Cancer cell.
[137] J. Dick,et al. Stem cell concepts renew cancer research. , 2008, Blood.
[138] Kevin Gross,et al. Positive interactions among competitors can produce species-rich communities. , 2008, Ecology letters.
[139] M. Stratton,et al. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing , 2008, Proceedings of the National Academy of Sciences.
[140] Robert Axelrod,et al. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. , 2008, Translational oncology.
[141] A. Marusyk,et al. Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. , 2008, Biochimica et biophysica acta.
[142] Mark Shackleton,et al. Efficient tumour formation by single human melanoma cells , 2008 .
[143] James R. Downing,et al. Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia , 2008, Science.
[144] M. Heinrich,et al. Molecular pathobiology of gastrointestinal stromal sarcomas. , 2008, Annual review of pathology.
[145] Jorge S. Reis-Filho,et al. Resistance to therapy caused by intragenic deletion in BRCA2 , 2008, Nature.
[146] Harold Varmus,et al. Seeding and Propagation of Untransformed Mouse Mammary Cells in the Lung , 2008, Science.
[147] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[148] P. Vineis,et al. The microenvironments of multistage carcinogenesis. , 2008, Seminars in cancer biology.
[149] R. Weinberg,et al. Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.
[150] J. Klawitter,et al. Irradiation alters selection for oncogenic mutations in hematopoietic progenitors. , 2009, Cancer research.
[151] G. Parmigiani,et al. Design and analysis issues in genome-wide somatic mutation studies of cancer. , 2009, Genomics.
[152] S. Devries,et al. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma , 2009, Modern Pathology.
[153] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[154] N. Balaban,et al. The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. , 2009, FEMS microbiology reviews.
[155] D. Wilson. Tissue , 2009, The Lancet.
[156] B. Frieden,et al. Adaptive therapy. , 2009, Cancer research.
[157] Jun Luo,et al. Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer , 2009, Nature Medicine.
[158] Izhak Haviv,et al. Co-evolution of tumor cells and their microenvironment. , 2009, Trends in genetics : TIG.
[159] Paul Marjoram,et al. Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers , 2009, Proceedings of the National Academy of Sciences.
[160] P. Sorger,et al. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.
[161] M. Gönen,et al. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. , 2010, The Journal of clinical investigation.